Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach §130 c SGB V zu dem Arzneimittel Ublituximab
GWQ ServicePlus AG tender for Healthcare & Medical, worth €1, published in April 2026.
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime
Contract description
Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach §130 c SGB V zu dem Arzneimittel Ublituximab (Briumvi)
Other tenders · GWQ ServicePlus AG
The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Winners and award dates are hidden on the public page. Sign up free to see them →
- ocds-ted-146900-2026Not disclosed03 Mar 2026 Healthcare
- ocds-ted-142448-2026Not disclosed02 Mar 2026 Healthcare
- ocds-ted-303271-2026Not disclosed27 Feb 2026 Healthcare
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime